This Article Abstract Free Full Text (Free PDF) Free All Versions of this Article: 0192623308320280v1 36/5/720    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hong, H.-H. L. Articles by Lahousse, S. A. Search for Related Content PubMed PubMed Citation Articles by Hong, H.-H. L. Articles by Lahousse, S. A. Social Bookmarking                         What's this?

Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene

¹ Cellular and Molecular Pathology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
² College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA
³ Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA
⁴ Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA

Correspondence: Hue-Hua L. Hong, National Institute of Environmental Health Sciences, MD C1-04, 111 Alexander Dr., Research Triangle Park, NC 27709, USA; e-mail:hong5{at}niehs.nih.gov.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
The incidences of alveolar/bronchiolar adenomas and carcinomas in cumene-treated B6C3F1 mice were significantly greater than those of the control animals. We evaluated these lung neoplasms for point mutations in the K-ras and p53 genes that are often mutated in humans. K-ras and p53 mutations were detected by cycle sequencing of PCR-amplified DNA isolated from paraffin-embedded neoplasms. K-ras mutations were detected in 87% of cumene-induced lung neoplasms, and the predominant mutations were exon 1 codon 12 G to T transversions and exon 2 codon 61 A to G transitions. P53 protein expression was detected by immunohistochemistry in 56% of cumene-induced neoplasms, and mutations were detected in 52% of neoplasms. The predominant mutations were exon 5, codon 155 G to A transitions, and codon 133 C to T transitions. No p53 mutations and one of seven (14%) K-ras mutations were detected in spontaneous neoplasms. Cumene-induced lung carcinomas showed loss of heterozygosity (LOH) on chromosome 4 near the p16 gene (13%) and on chromosome 6 near the K-ras gene (12%). No LOH was observed in spontaneous carcinomas or normal lung tissues examined. The pattern of mutations identified in the lung tumors suggests that DNA damage and genomic instability may be contributing factors to the mutation profile and development of lung cancer in mice exposed to cumene.

Key Words: K-ras • p53 • cumene • lung • mouse

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Lung cancer is the most frequently diagnosed cancer in the world and the most common cause of cancer mortality worldwide. This high mortality rate is largely owing to the late stage of diagnosis and the poor response to therapy. The need to develop better diagnostic techniques and therapies is urgent. Mouse models have been used to study carcinogenesis of human lung cancers, and many of the major genetic alterations detected in human lung cancers have also been identified in mouse lung tumors.

Mouse alveolar/bronchiolar adenomas and carcinomas, which are common spontaneous and chemical-induced lung tumors in mice, are similar to human adenocarcinomas in histomorphology and molecular characteristics, including activation of the K-ras gene (Meuwissen and Berns 2005; Nikitin et al. 2004). The patterns of mutations in cancer genes, such as ras and p53, have been found to aid in the understanding of tumorigenesis in rodents and humans (Harris 1993; Le Calvez et al. 2005; Maronpot et al. 1995; Osada and Takahashi 2002; Reynolds 1987). For example, in some neoplasms, the profile of activating mutations in ras genes or inactivating mutations in the p53 gene is specific for particular chemicals and differs from those detected in spontaneous neoplasms (Sills et al. 1999; Sills et al. 2004).

Cumene, or isopropylbenzene, is a constituent of crude oil used primarily for the production of phenol and acetone. It is a good solvent for fats and resins and has been suggested as a replacement for benzene in many industrial applications. The annual production of cumene in the United States is high and increasing, with 4.49 billion pounds produced in 1993 (National Library of Medicine Hazardous Substance Data Bank 2000). Because it is a major commodity chemical, there is a high potential for many workers to be exposed to cumene. The most probable route of human exposure is inhalation of contaminated air (Jackson 1985) from cumene evaporated into the environment during production and processing from petroleum refining, combustion of petroleum products, and use of a variety of products containing cumene.

National Toxicology Program (NTP) two-year, whole-body–inhalation studies revealed that treatment of B6C3F1 mice with cumene significantly increased the incidence of alveolar/bronchiolar adenomas and carcinomas in all groups of exposed males and females. Cumene is not genotoxic, which was demonstrated by several studies involving bacterial and mammalian cells in culture and in in vitro studies involving mice and rats (NTP 1996; National Library of Medicine Hazardous Substance Data Bank 2003; US Environmental Protection Agency 1997). In vitro cell transformation assays using BALB/3T3 mouse embryo cells and unscheduled DNA synthesis assays using rat primary hepatocytes yielded conflicting results regarding a cumene effect that were not reproducible. Cumene was weakly positive with no clear dose response for the induction of micronuclei in rat bone marrow at doses ranging from 78 to 2500 mg/kg intraperitoneally (NTP 1996).

The goal of this study was to evaluate both spontaneous and cumene-induced lung neoplasms for mutations in the K-ras and p53 genes, which are considered important in the pathogenesis of human lung cancer. Another goal was to identify chemical-specific mutations that might serve as biomarkers of occupational exposure with possible relevance to human health.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Lung Neoplasms
Male and female B6C3F1 mice were exposed to 0, 125 (females only), 250, 500, or 1000 (males only) ppm cumene (50 animals per group) by whole-body inhalation, six hours per day, five days per week for two years (NTP, CAS Number 98-82-8). Incidences of cumene-induced lung tumors were evaluated using the poly-3 test. Husbandry and experimental procedures were in compliance with the requirements set forth by the Public Health Service’s Guide for the Care and Use of Laboratory Animals. At necropsy, tissues were fixed in 10% neutral-buffered formalin, routinely processed, embedded in paraffin, sectioned to a thickness of 5 µm, and stained with hematoxylin and eosin. Subsequently, five unstained serial sections, 10 µm thick, were prepared from paraffin blocks containing alveolar/bronchiolar adenomas or carcinomas. To isolate adequate amounts of DNA, neoplasms greater than 1 mm in diameter were identified for analysis. Fifty-two cumene-induced alveolar/bronchiolar neoplasms (six adenomas and forty-six carcinomas), seven spontaneously occurring carcinomas, and six normal lung tissues were evaluated for K-ras mutations in exons 1 and 2 (codons 12, 13, and 61) and p53 mutations in exons 5–8.

DNA Isolation, Amplification, and Cycle Sequencing
DNA was isolated and extracted from paraffin-embedded sections containing lung neoplasms and normal lung tissues and amplified by PCR. Details of the use of nested primers for K-ras and p53 genes have been described previously (Lambertini et al. 2005; Sills et al. 1995). Positive DNA controls for K-ras and p53 mutations and controls lacking DNA were run with all sets of reactions. PCR products were purified using a QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, USA). The purified samples were sequenced using a cycle-sequencing kit (US Biochemical, Cleveland, OH, USA), which incorporated [-³³p]-dideoxynucleotide triphosphate (ddNTP) terminators (A, C, G, T) into the sequencing products. Detected mutations were confirmed by repeat analysis, starting from amplification of the original DNA extract.

Immunohistochemistry for p53 Protein
Alveolar/bronchiolar adenomas and carcinomas were examined for p53 protein expression by immunohistochemical analysis, using an avidin-biotin-peroxidase detection system (Vectastain Rabbit Elite Kit, Vector Laboratories, Burlingame, CA, USA). The immunohistochemical staining for expression of mutant p53 protein was performed as previously described (Hsu et al. 1981; Hong et al. 2000; Hong et al. 2003; Maronpot et al. 1993; Sills et al. 2004). A 1:300 dilution of the primary polyclonal rabbit antibody CM-5 (Vector Laboratories, Burlingame, CA, USA), which detects accumulation of the mutant p53 in rodents, was used. Normal rabbit serum (Vector Laboratories, Burlingame, CA, USA) was used as the negative control in place of the primary antibody. Tissue specimens from a p53 transgenic mouse (mutation in codon 135 of p53) served as the positive control.

Loss of Heterozygosity (LOH) Analysis
Microsatellite marker Mts 1 near the p16 tumor suppressor gene on chromosome 4 was used to amplify polymorphic regions between strain C57BL/6 (B) and C3H/He (H) mice (Jackson Laboratories, Bar Harbor, ME, USA) to identify portions of tumors with LOH at the p16 locus. The Mts 1 forward (5'-GA TTT CTA CGG AAA GCC CTG-3') and reverse (5'-TAT TGT GCA TTT GTG TGT CTG G-3') primers were located 2395 and 2172 bp upstream of the translational start site, respectively. PCR amplification was performed on forty cumene-induced lung neoplasms (thirty-six carcinomas, four adenomas) and seven spontaneous B6C3F1 carcinomas. Controls lacking DNA were included with all amplifications. The PCR products were resolved on 4% NuSieve (FMC BioProducts, Rockland, ME, USA)–agarose (3:1) to separate B and H alleles.

The inner PCR products from paraffin-embedded plus eight frozen treated neoplasms (seven carcinomas and one adenoma) were labeled by incorporation with [-³³p]-dATP (MP/ICN Biomedicals, Irvine, CA, USA), using single-stranded conformation polymorphism (SSCP) analysis to distinguish between the H and B alleles on a 0.5X MDE (Cambrex Bio Science, Rockland, ME, USA) gel at 3W for fifteen hours at room temperature.

To determine LOH in fifty cumene-induced lung neoplasms (forty-six carcinomas, four adenomas) and seven spontaneous carcinomas at marker D6MC012 near the K-ras gene on chromosome 6 in B6C3F1 mice, SSCP analysis was used. PCR amplification with [-³³p]-labeled and unlabeled dATP was performed as described previously (Sills et al. 2004). The MDE gel was electrophoresed at 3W at room temperature for fifteen hours to separate the H and B alleles. The gels were dried and exposed to x-ray film overnight.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mutation Analysis
The incidence of alveolar/bronchiolar adenomas and carcinomas in male and female treated groups was significantly greater than those of the controls (Table 1). A higher frequency of K-ras mutations (45/52, 87%) was observed in the cumene-induced lung neoplasms, as compared to spontaneous lung neoplasms from control animals (historical 33/117, 28%; concurrent 1/7, 14%) (Table 2). These mutations were observed in 91% (41/45) of males and 57% (4/7) of females. K-ras mutations were detected in 67% (4/6) of the adenomas (one in codon 13 and three in codon 61) and in 89% (41/46) of the carcinomas. The predominant K-ras mutations were codon 12 GTT (G to T transversions) and codon 61 CGA (A to G transitions). Three codon 12 CGT mutations and one codon 61 CTA mutation were found in the cumene-induced neoplasms, but none were found in spontaneous lung neoplasms (0/124, concurrent controls combined with historical controls) (Table 2; Figures 1 and 2). There was no significant increase in the incidence of mutations at codon 13 in the cumene-induced lung neoplasms.

View larger version (43K): [in this window] [in a new window]   Figure 1 Identification of K-ras mutations in codon 12 of lung neoplasms from B6C3F1 mice exposed to cumene by whole-body inhalation for two years. Sequencing panels are from left to right: (a) normal K-ras codon 12 sequence GGT: (b) mutated codon 12 sequence GTT from animal No. 819 carcinoma; (c) mutated codon 12 sequence CGT from animal No. 808 carcinoma. Arrows point to mutant bands.

View larger version (28K): [in this window] [in a new window]   Figure 2 Identification of K-ras codon 61 mutations in cumene-induced lung neoplasms from B6C3F1 mice by cycle sequencing of amplified exon 2. Sequencing panels are from left to right: (a) normal codon 61 sequence CAA; (b) mutated sequence CGA from animal No. 604 adenoma; (c) mutated sequence CAC from animal No. 430 carcinoma; (d) mutated sequence CTA from animal No. 824 carcinoma. Arrows point to mutant bands.

View larger version (158K): [in this window] [in a new window]   Figure 3 Alveolar/bronchiolar carcinoma from a male mouse exposed to 1000 ppm cumene. Note p53 protein expression (brown chromogen) in the nucleus of malignant epithelial cell, 400X.

View larger version (52K): [in this window] [in a new window]   Figure 4 Examples of sequencing p53 exon 5 mutations in lung neoplasms from B6C3F1 mice exposed to cumene. Sequencing panels a, c, and e are normal p53 sequences, and panels b, d, and f are mutated sequences at indicated codons from animal No. 402 carcinoma, animal No. 840 carcinoma, and animal No. 601 carcinoma. The wild-type allele was not detected in the sequencing reaction shown in panel d.

LOH Analysis
LOH on chromosome 6 near the K-ras gene was observed in 6/50 (12%; 4–H and 2–B) treated carcinomas, 0/6 of adenomas, and 0/7 of the spontaneous carcinomas examined (Figure 5). LOH of the C3H/He allele (H) was observed in 5/40 (13%) cumene-induced carcinomas, 1/6 of adenomas, and 0/7 of the spontaneous carcinomas examined at the microsatellite marker on chromosome 4 near the p16 gene (Figure 6).

View larger version (28K): [in this window] [in a new window]   Figure 5 SSCP analysis at marker D6MC012 to assess LOH on chromosome 6 near K-ras gene in cumene-induced carcinomas. Lanes 3-5 represent normal (N) lungs from B6C3F1 (F1), C3H (H) and C57BL/6 (B) inbred mouse strains. Lane 2 (animal No. 644 carcinoma) showed loss of C3H (H) allele; lane 6 (animal No. 846 carcinoma) showed loss of C57 (B) allele; lane 1 (animal No. 828 carcinoma) appeared normal, with both alleles present.

View larger version (33K): [in this window] [in a new window]   Figure 6 SSCP analysis at Mts 1 to assess LOH on chromosome 4 near p16 tumor suppressor gene in cumene-induced carcinomas. Lanes 2–4 represent normal (N) lungs from B6C3F1 (F1), C3H (H) and C57 (B) inbred mouse strains. Lane 1 (animal No. 324 carcinoma) showed loss of the C3H (H) allele; lane 5 (animal No. 834 carcinoma) appeared normal, with both alleles present.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

The high frequency and pattern of K-ras mutations in mouse lung tumors may directly depend on the nature of the chemical carcinogen or its metabolites. In our study, the development of lung neoplasms in B6C3F1 mice exposed to cumene may involve multiple carcinogenic processes including direct DNA damage and/or indirect DNA damage. Metabolites of cumene may have caused DNA adducts and subsequent point mutations. Side-chain oxidation of cumene (isopropylbenzene) is rapid and extensive and occurs in both hepatic and extrahepatic tissues including the lung (Sato and Nakajima 1987), with the secondary alcohol 2-phenyl-2-propanol being the principal metabolite in rats (Research Triangle Institute 1989; US Environmental Protection Agency 1997) and humans (Lee 1987; Meuwissen and Berns 2005; US Environmental Protection Agency 1997). The C-isopropyl bonds are readily cleaved, and the remaining electrophilic carbon moiety may form DNA adducts and cause subsequent DNA damage. Previous studies showed that the related benzene is carcinogenic and genotoxic (Abemethy et al. 2004; Gut et al. 1996; Snyder and Hedli 1996; Valentine et al. 1996).

Alternatively indirect damage from oxidative stress may have contributed to the mutations. G to T transversions are commonly detected DNA base changes associated with active oxygen species and are consistent with 8-OH-G adducts produced during oxidative damage to DNA (Janssen et al. 1993; Kino and Sugiyama 2005; Shigenaga and Ames 1991; Tchou et al. 1991). In other studies, exposure of B6C3F1 mice to ozone or vanadium pentoxide is thought to result in the generation of hydroxyl radicals, which induce a G to T transversion at codon 12 of K-ras gene (Devereux et al. 2002; Sills et al. 1995). Interestingly, G to T transversion in K-ras codon 12 is the most common mutation detected in human adenocarcinomas (Rodenhuis et al. 1987). In human lung tumors, K-ras mutations appear to correlate with DNA adducts of benzo(a)pyrene and are associated with smoking (Santillo et al. 2001). It is possible that smoking in combination with cumene exposure in humans may have an additive effect on K-ras mutations.

Although K-ras appears to play a critical role in mouse and human lung adenocarcinoma formation, its function is complex. Zhang et al. (2001) proposed that wild-type K-ras may be a mouse lung tumor suppressor gene. Further LOH analysis in cumene-induced lung neoplasms demonstrated allelic loss on chromosome 6 near the K-ras gene in six carcinomas and on chromosome 4 near p16 tumor suppressor gene in five carcinomas. Allele loss of p16 has been detected in human cancers (de Vos et al. 1995; Kratzke et al. 1996) and mouse lung tumors (Patel et al. 2000).

A high frequency (52%) of p53 mutations was detected in cumene-induced alveolar/bronchiolar neoplasms that were correlated by immunohistochemistry with increased p53 protein expression (56%). The presence of p53 protein expression without p53 gene mutation could be a result of mutations outside exons 5–8 or possibly owing to alterations of other proteins downstream of p53 (Greenblatt et al. 1994). The predominance of cumene-induced alveolar/bronchiolar neoplasms that contain p53 mutations may provide a selective advantage for unregulated growth and the avoidance of apopto-sis (Greenblatt et al. 1994; Harris 1996; Osada and Takahashi 2002; Rodin and Rodin 2005). A study of aflatoxin-B1 (AFB1)-induced mouse lung tumors found a high proportion (> 70%) of tumors with p53 accumulation and mutations (Tam et al. 1999), and lung tumors of mice exposed transpla-centally to AZT also had a high proportion (84%) of p53 mutations (Hong et al. 2007). Other studies such as methylene-chloride–induced mouse lung tumors (Hegi et al. 1993), ozone-induced, and vanadium-pentoxide–induced mouse lung tumors (Devereux et al. 2002; Sills et al. 2004) exhibited no or low frequency of p53 mutations. Unlike the mostly random mutation pattern for the AFB1-induced tumors (Tam et al. 1999), the cumene-induced tumors displayed specific p53 mutations. P53 mutations were observed only in exon 5 (24/27, 89%) and exon 7 (3/27, 11%). The mutations observed in the p53 gene in cumene-exposed mice clearly imply this genetic event is related to chemical exposure, since these mutations were not detected in spontaneous tumors.

In conclusion, the patterns of K-ras and p53 mutations identified in the cumene-induced lung tumors suggest that DNA damage and genomic instability may be the contributing factors to the mutation profile and development of lung cancer in these mice. The molecular alterations identified in the cumene-induced lung neoplasms appear to affect the same pathways as those reported in human lung cancer, suggesting that the response in the mouse may be of relevance to humans. Futher research of the cumene mouse lung tumors by microarray analysis underscores the complexity of lung cancer where, in addition to genetic factors, signal transduction pathways and epigenetic mechanisms are also contributing factors to the car-cinogenesis process (Wakamatsu et al. forthcoming).

	Acknowledgments

 
The authors thank Dr. Darlene Dixon and Dr. Mark Cesta for their critical review of this manuscript. This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 
Abemethy, DJ, Kleymenova, EV, Rose, J, Recio, L, & Faiola, B. (2004). Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone. Toxicol Sci, 79, 82-89[Abstract/Free Full Text]

Chad, AE, & Geoff, C. (2000). The importance of being K-ras. Cell Signal, 12, 425-34[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Devereux, TR, Holliday, W, Anna, C, Ress, N, Roycroft, J, & Sills, RC. (2002). Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis, 23, 1737-43[Abstract/Free Full Text]

de Vos, S, Miller, CW, Takeuchi, S, Gombart, AF, Cho, SK, & Koeffler, HP. (1995). Alterations of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes Cancer, 14, 164-70[Web of Science][Medline] [Order article via Infotrieve]

Greenblatt, MS, Bonnett, WP, Hollstein, M, & Harris, CC. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78[Free Full Text]

Gut, I, Nedelcheva, V, Soucek, P, Stopka, P, & Tichavska, B. (1996). Cytochromes p450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect, 104(Suppl_6), 1211-18[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Harris, CC. (1993). P53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-81[Free Full Text]

Harris, CC. (1996). P53 tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective. Carcinogenesis, 17, 1187-98[Free Full Text]

Hazardous Substance Data Bank (HSDB). (2000). Cumene (CASRN: 98-82-8): Annual Production in U.S. Chemical and Engineering News, 72, 13, Toxicology & Environmental Health Information Program, National Library of Medicine: Bethesda, MD. USA. (4/11/94). (http://toxnet.nlm.nih.gov).

Hazardous Substance Data Bank (HSDB). (2003). Cumene. Toxicology Information Program. Bethesda, MD, USA: National Library of Medicine

Hegi, ME, Soderkvist, P, Foley, JF, Schoonhoven, R, Swenberg, JA, Kari, F, Maronpot, R, Anderson, MW, & Wiseman, RW. (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-10[Abstract/Free Full Text]

Hong, HL, Devereux, TR, Melnick, RL, Boorman, GA, & Sills, RC. (2000). Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol Pathol, 28, 529-34[Abstract/Free Full Text]

Hong, HL, Ton, TV, Devereux, TR, Moomaw, C, Clayton, N, Chan, P, Dunnick, JK, & Sills, RC. (2003). Chemical-specific alterations in ras, p53, and β-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol, 191, 227-34[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hong, HL, Dunnick, J, Herbert, R, Devereux, TR, Kim, Y, & Sills, RC. (2007). Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Environ Mol Mutagen, 48, 299-306[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Hsu, SM, Raine, L, & Fanger, H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem, 29, 577-80[Abstract]

Jackson, L. (1985). Test Rule Support Document Cumene (pp.170, Syracuse, NY: Syracuse Research Corporation. SRC-TR-85-098.

Janssen, YMW, Van Houten, B, Borm, PJA, & Mossman, BT. (1993). Cell and tissue responses to oxidative damage. Lab Invest, 69, 261-74[Web of Science][Medline] [Order article via Infotrieve]

Kino, K, & Sugiyama, H. (2005). UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutation Res, 571, 33-42[Medline] [Order article via Infotrieve]

Kratzke, RA, Greatens, TM, Rubins, JB, Maddaus, MA, Niewoehner, DE, Niehans, GA, & Geradts, J. (1996). Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res, 56, 3415-20[Abstract/Free Full Text]

Lambertini, L, Surin, K, Ton, TT, Clayton, N, Dunnick, J, Kim, Y, Hong, HL, Devereux, TR, & Sills, RC. (2005). Analysis of p53 tumor suppressor gene, H-ras protooncogene and profilerating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/SKh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy). Toxicol Pathol, 33, 292-99[Abstract/Free Full Text]

Le Calvez, F, Mukeria, A, Hunt, JD, Kelm, O, Hung, RJ, Taniere, P, Brennan, P, Boffetta, P, Zaridze, DG, & Hainaut, P. (2005). TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res, 65, 5076-83[Abstract/Free Full Text]

Lee, EW. In Snyder, R (Ed.). (1987). Cumene, Section 1.5. Ethel Browning’s Toxicity and Metabolism of Industrial Solvents, Hydrocarbons, I, (2). New York, NY: Elsevier Science Publishers

Maronpot, R, Anderson, MW, & Wiseman, RW. (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-10[Abstract/Free Full Text]

Maronpot, RR, Fox, T, Malarkey, D, & Goldsworthy, T. (1995). Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology, 101, 125-56[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Meuwissen, R, & Berns, A. (2005). Mouse models for human lung cancer. Genes Dev, 19, 643-64[Abstract/Free Full Text]

National Toxicology Program (NTP). (1996). In Vivo Cytogenetics Testing Results for Cumene, Micronucleus Induction Results. Research Triangle Park, NC: NIEHS. (Case No. 98-82-8) NTP TR 542.

Nikitin, AY, Alcaraz, A, Anver, MR, Bronson, RT, Cardiff, RD, Dixon, D, Fraire, AE, Gabrielson, EW, Gunning, WT, Haines, DC, Kaufman, MH, Linnoila, RL, Maronpot, RR, Rabson, AS, Reddick, RL, Rehm, S, Rozengurt, N, Schuller, HM, Shmidt, EN, Travis, WD, Ward, JM, & Jacks, T. (2004). Classification of proliferative pulmonary lesions of the mouse recommendations of the mouse models of human cancers consortium. Cancer Res, 64, 2307-16[Abstract/Free Full Text]

Osada, H, & Takahashi, T. (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 21, 7421-34[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Patel, AC, Anna, CH, Foley, JF, Stockton, PS, Tyson, FL, Barrett, JC, & Devereux, TR. (2000). Hypermethylation of the p16Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Carcinogenesis, 21, 1691-1700[Abstract/Free Full Text]

Research Triangle Institute (RTI). (1989). Metabolism, Disposition and Pharmacokinetics of Cumene in F 344 Rats Following Oral. IV Administration or Nose-Only Inhalation Exposure. Research Triangle Park, NC: RTI. RTI/4353-01F.

Reynolds, SH, Stowers, SJ, Patterson, RM, Maronpot, RR, Aaronson, SA, & Anderson, MW. (1987). Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science, 237, 1309-16[Abstract/Free Full Text]

Rodenhuis, S, Van De Watering, ML, Mooi, WJ, Evers, SG, Van Zandwijk, N, & Bos, JL. (1987). Mutational activation of the K-ras oncogene—a possible pathogenetic factor in adenocarcinoma of the lung. New Engl J Med, 317, 929-35[Abstract]

Rodin, SN, & Rodin, AS. (2005). Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol, 15, 103-12[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Santillo, M, Mondola, P, Seru, R, Annella, T, Cassano, S, Ciullo, I, Tecce, MF, Iacomino, G, Damiano, S, Cuda, G, Paterno, R, Martignetti, V, Mele, E, Feliciello, A, & Avvedimento, EV. (2001). Opposing functions of Ki- and Ha-ras genes in the regulation of redox signals. Curr Biol, 11, 614-19[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sato, A, & Nakajima, T. (1987). Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health, 13, 81-93[Web of Science][Medline] [Order article via Infotrieve]

Shigenaga, MK, & Ames, BN. (1991). Assays for 8-hydroxy-2'-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radical Biol Med, 10, 211-16[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sills, RC, Hong, HL, Greenwell, A, Herbert, RA, Boorman, GA, & Devereux, TR. (1995). Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis, 16, 1623-28[Abstract/Free Full Text]

Sills, RC, Hong, HL, Melnick, RL, Boorman, GA, & Devereux, TR. (1999). High frequency of codon 61 K-ras A to T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis, 20, 657-62[Abstract/Free Full Text]

Sills, RC, Hong, HL, Flake, G, Moomaw, C, Clayton, N, Boorman, GA, Dunnick, J, & Devereux, TR. (2004). O-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis. Carcinogenesis, 25, 605-12[Abstract/Free Full Text]

Snyder, R, & Hedli, CC. (1996). An overview of benzene metabolism. Environ Health Perspect, 104 (Suppl 6), 1165-71[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Tam, AS, Foley, JF, Devereux, TR, Maronpot, RR, & Massey, TE. (1999). High frequency and heterogenous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Cancer Res, 59, 3634-40[Abstract/Free Full Text]

Tchou, J, Kasai, H, Shibutani, S, Chung, M-H, Laval, J, Grollamn, AP, & Nishimura, S. (1991). 8-Oxogyanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA, 88, 4690-94[Abstract/Free Full Text]

US Environmental Protection Agency (EPA). (1997). Toxicological Review of Cumene, EPA’s Summary Information on the Integrated Risk Information System. Washington, DC: EPA

Valentine, JL, Lee, SS, Seaton, MJ, Asgharian, B, Farris, G, Corton, JC, Gonzalez, FJ, & Medinsky, MA. (1996). Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol, 141, 205-13[Web of Science][Medline] [Order article via Infotrieve]

Wakamatsu, N, Collins, BC, Parker, JS, Tessama, M, Clayton, ND, Ton, TT, Hong, HL, Belinsky, S, Devereux, TR, Sills, RC, & Lahousse, SA. Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and modification of histone, contribute to the pathogenesis of cumene-induced lung tumors. Toxicol Pathol. (Forthcoming). (Forthcoming). (Forthcoming).

Zhang, Z, Wang, Y, Vikis, HG, Johnson, L, Liu, J, Anderson, MW, Sills, RC, Hong, HL, Devereux, TR, Jacks, T, Guan, KL, & You, M. (2001). Wild-type Kras 2 can inhibit lung carcinogenesis in mice. Nat Genet, 29, 25-33[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

This version was published on July 1, 2008

Toxicologic Pathology, Vol. 36, No. 5, 720-726 (2008)
DOI: 10.1177/0192623308320280


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. J. Hoenerhoff, H. H. Hong, T.-v. Ton, S. A. Lahousse, and R. C. Sills A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer Toxicol Pathol, December 1, 2009; 37(7): 835 - 848. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free All Versions of this Article: 0192623308320280v1 36/5/720    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hong, H.-H. L. Articles by Lahousse, S. A. Search for Related Content PubMed PubMed Citation Articles by Hong, H.-H. L. Articles by Lahousse, S. A. Social Bookmarking                         What's this?